http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2008044443-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-103 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
| filingDate | 2007-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2008044443-A1 |
| titleOfInvention | Gadolinium compound and contrast medium for MRI |
| abstract | (1) T1 mitigation ability is high, and can be imaged with high sensitivity even at a small dose, (2) excellent in systemic blood vessel and liver imaging, (3) excellent in pancreatic imaging, (4) 24 more Provided are a novel gadolinium compound that has the safety of being largely excreted outside the body within a time, and a contrast agent including the same. It is a gadolinium compound characterized by being represented by the following general formula (1). [Chemical 1] (In the formula, G 1 represents a residue obtained by reacting a sugar lactone with an amino group, and sugars of the sugar lactone are allose, altrose, mannose, gurose, idose, galactose, talose, ribose, arabinose, xylose, lyxose, erythrose. Represents Threose, Cellobiose, Maltose, Lactose or Maltriolose.) |
| priorityDate | 2006-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 124.